home / stock / reph / reph news

REPH News and Press, Recro Pharma Inc. From 08/23/23

Stock Information
Company Name: Recro Pharma Inc.
Stock Symbol: REPH
Market: NASDAQ
Website: recropharma.com
Menu
REPH REPH Quote REPH Short REPH News REPH Articles REPH Message Board
Get REPH Alerts

News, Short Squeeze, Breakout and More Instantly...
REPH - Societal CDMO Announces Appointment of Matt Arens to Board of Directors

SAN DIEGO and GAINESVILLE, Ga., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule th...
REPH - Societal CDMO Announces Proposed Public Offering of Common Stock

SAN DIEGO and GAINESVILLE, Ga., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (“CDMO”) dedicated to solving complex formulation and manufacturing challenges primarily in small mol...

REPH - Societal CDMO Reports Second Quarter 2023 Financial Results

Recorded Q2 Revenue of $21.8 Million Signed Multiple New Business Agreements with New and Existing Customers Secured Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency; Allows Expansion into Manufacture of Psychedelic Drug Products Company t...

REPH - Societal CDMO Reschedules Second Quarter 2023 Financial Results Reporting to August 14, 2023

SAN DIEGO and GAINESVILLE, Ga., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges pr...
REPH - Societal CDMO to Report Financial Results for Second Quarter 2023 on August 9, 2023

SAN DIEGO and GAINESVILLE, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges pr...

REPH - Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market

Company Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25 Years of Manufacturing of Schedule 2 Products No Additional Investment Required to Support Clinical Trials for Psychedelic-Based Therapeutics SAN DIEGO and GAINESVILLE, ...

REPH - Societal CDMO Selected by Spinnaker Biosciences to Provide CDMO Services to Support Clinical Development of Novel Therapeutic Candidate

SAN DIEGO and GAINESVILLE, Ga., July 10, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; Nasdaq: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule ...
REPH - Societal CDMO Signs Master Service Agreement With CivicaScript to Provide CDMO Services

SAN DIEGO and GAINESVILLE, Ga., June 29, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule th...

REPH - Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator

SAN DIEGO and GAINESVILLE, Ga., May 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; Nasdaq: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule t...

REPH - Societal CDMO Reports First Quarter 2023 Financial Results

Recorded Q1 Revenue of $21.5 Million Signed Multiple New Business Agreements with New and Existing Customers Granted FDA Approval for Manufacture of First Commercial Tablet Product Company to Host Webcast Today at 4:30 p.m. ET SAN DIEGO and GAINESVILLE, Ga., May 10...
Previous 10 Next 10